RTP Formulation & Sterile Fill-Finish Facility
More Content From RTP Formulation & Sterile Fill-Finish Facility
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.White Papers / Tech Papers Released on 06.28.2021
-
On-Demand Webinar: Microbial In-Use Studies
In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.News Releases Released on 06.28.2021
-
QBD Addresses API Supply in Orphan Drug Formulation
Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.Case Studies Released on 06.28.2021
-
On-Demand Lab Open House
Sign up to get a close-up look at our US network of laboratories and hear about our expansion plans.News Releases Released on 06.28.2021
-
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.News Releases Released on 06.28.2021
-
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.News Releases Released on 03.18.2021
-
Pharmaceutical and Biotherapeutic Development and Testing
Formulation and Method Development.Literature / Brochures Released on 01.13.2021
-
Drug Product Development, Manufacturing, and Packaging
Parenteral Forms.Literature / Brochures Released on 01.11.2021
-
The Changing R&D Landscape
Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)White Papers / Tech Papers Released on 01.07.2021
-
Alcami Expands Oral Solid Capabilities with Investment in Wilmington, NC
...News Releases Released on 01.07.2021
-
Structural Characterization of Biologics Using High-Resolution Mass Spectrometry
High-resolution mass spectrometry is a key component in the characterization of novel biologics and biosimilars.White Papers / Tech Papers Released on 01.06.2021
-
The Importance of Food Studies in Pharmaceutical Development
Alternate methods of administering solid oral formulations are necessary to meet the needs of all patients.White Papers / Tech Papers Released on 01.05.2021
-
ICP-MS - Leveraging Inductively Coupled Plasma Mass Spectrometry To Its Full Potential
by Chris Williams, Julia Spraul (pictured), and Alyssa McBurneyWhite Papers / Tech Papers Released on 12.17.2020
Related Content
